Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
---|
05/28/2009 | WO2009067686A2 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof |
05/28/2009 | WO2009067674A2 Polymorphs of sunitinib base and processes for preparation thereof |
05/28/2009 | WO2009067600A2 Biaryl pde4 inhibitors for treating inflammation |
05/28/2009 | WO2009067405A1 Substituted pyrazinyl amide compounds as modulators of the histamine h3 receptor |
05/28/2009 | WO2009067081A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
05/28/2009 | WO2009066775A1 Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same |
05/28/2009 | WO2009066774A1 Selective expression inhibitor for aurora kinase a and aurora kinase b genes |
05/28/2009 | WO2009066084A1 2 -morpholinopyrimidines and their use as pi3 kinase inhibitors |
05/28/2009 | WO2009048752A3 Insecticidal substituted azinyl derivatives |
05/28/2009 | WO2009048750A3 Insecticidal (1,3,5)-triazinyl phenyl hydrazones |
05/28/2009 | WO2009045700A3 5-lipoxygenase-activating protein (flap) inhibitors |
05/28/2009 | WO2008020453A3 A process for the preparation of a novel crystalline polymorph of aripiprazole |
05/28/2009 | US20090137815 Process for Making Cytokine Inhibiting Compounds Containing 4- and 5-Imidazolyl Rings and the Intermediates Thereof |
05/28/2009 | US20090137802 A2b adenosine receptor antagonists |
05/28/2009 | US20090137800 Novel compound, optical filter and optical recording material using the same |
05/28/2009 | US20090137796 Methods for the preparation of taxanes using chiral auxiliaries |
05/28/2009 | US20090137655 Non-Steroidal Ligands for the Glucocorticoid Receptor, Compositions and Uses Thereof |
05/28/2009 | US20090137648 Process for the preparation of irbesartan hydrochloride |
05/28/2009 | US20090137637 Tetrazolyl-Methylene Amino Acid Derivatives |
05/28/2009 | US20090137615 Indazolylamino quinazoline derivatives as antitumour agents |
05/28/2009 | US20090137600 Antiplatelet agent and process for producing the same |
05/28/2009 | US20090137594 Pentafluorosulphanyl-Substituted Compound And Its Use For Producing Medicaments |
05/28/2009 | US20090137589 Stereoisomerically Enriched 3-Aminocarbonyl Bicycloheptene Pyrimidinediamine Compounds And Their Uses |
05/28/2009 | US20090137588 Heteroaryl compounds and uses thereof |
05/28/2009 | US20090137586 Compounds for the treatment of inflammatory disorders |
05/28/2009 | US20090137570 Inhibitors of cathepsin s |
05/28/2009 | US20090137560 Imidazole compounds having pharmaceutical activity towards the sigma receptor |
05/28/2009 | US20090137559 Bazedoxifene ascorbate |
05/28/2009 | US20090137558 Pyridine based compounds useful as intermediates for pharmaceutical or agricultural end-products |
05/28/2009 | US20090137524 Substituted arylpyrazoles |
05/28/2009 | US20090137021 Anti-inflammatory medicaments |
05/28/2009 | US20090136596 P38 inhibitors and methods of use thereof |
05/28/2009 | US20090134784 Carbazole-containing materials in phosphorescent light emitting diodes |
05/28/2009 | US20090134783 Materials for organic light-emitting diodes |
05/28/2009 | CA2722582A1 Biaryl pde4 inhibitors for treating inflammation |
05/28/2009 | CA2706536A1 Amorphous body composed of heterocyclic compound, solid dispersion and pharmaceutical preparation each comprising the same, and process for production of the same |
05/28/2009 | CA2704214A1 Pyrimidine derivatives for the treatment of asthma, copd, allergic rhinitis, allergic conjunctivitis, atopic dermatitis, cancer, hepatitis b, hepatitis c, hiv, hpv, bacterial infections and dermatosis |
05/28/2009 | CA2699306A1 Sunitinib hemi-l-malate, polymorphs and preparation thereof, polymorphs of racemic sunitinib malate, compositins containing sunitinib base and malic acid and preparation thereof |
05/28/2009 | CA2699305A1 Polymorphs of sunitinib base and processes for preparation thereof |
05/27/2009 | EP2062889A1 Compounds |
05/27/2009 | EP2062887A1 Novel aminopyridine derivative having aurora a-selective inhibitory activity |
05/27/2009 | EP2062583A2 Therapeutic applications of pro-apoptotic benzodiazepines |
05/27/2009 | EP2061786A2 Indazole derivatives as modulators of interleukin-1 receptor-associated kinase |
05/27/2009 | EP2061785A2 Linear pyridazine and pyrrole compounds, processes for obtaining them and uses |
05/27/2009 | EP2061782A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
05/27/2009 | EP2061779A1 Aryl sulfonamides with an analgesic action |
05/27/2009 | EP2061774A2 Arylpiperazine derivatives and uses thereof |
05/27/2009 | EP2061773A2 Quinazoline based egfr inhibitors containing a zinc binding moiety |
05/27/2009 | EP2061770A1 Piperazine compounds with herbicidal action |
05/27/2009 | EP2061768A2 Imidazole-4,5-dicarboxamide derivatives as jak-2 modulators |
05/27/2009 | EP2061766A2 Novel compounds |
05/27/2009 | EP2061762A2 Pyrazine compounds, their use and methods of preparation |
05/27/2009 | EP2061758A1 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
05/27/2009 | EP1912706A4 Novel 5-substituted indole derivatives as dipeptidyl peptidase iv (dpp-iv) inhibitors |
05/27/2009 | EP1776358B1 Substituted propenyl piperazine derivatives as novel inhibitors of histone deacetylase |
05/27/2009 | EP1725544B1 3-[4-heterocyclyl-1,2,3-triazol-1-yl]-n-aryl-benzamides as inhibitors of the cytokines production for the treatment of chronic inflammatory diseases |
05/27/2009 | EP1663241B1 5-arylpyrimidines as anticancer agents |
05/27/2009 | EP1519915B1 Tricyclic steroid hormone nuclear receptor modulators |
05/27/2009 | EP1222174B1 Imidazol-4-ylmethanols used as inhibitors of steroid c17-20 lyase |
05/27/2009 | EP1171424B1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors |
05/27/2009 | EP1095275B1 Endogenous constitutively activated g protein-coupled orphan receptors |
05/27/2009 | CN101443327A Chromanylurea compounds that inhibit vanilloid receptor subtype 1 (VR1) receptor and uses thereof |
05/27/2009 | CN101443318A Heterobicyclic carboxamides as inhibitors for kinases |
05/27/2009 | CN101443316A 1,5-diphenylpyrazoles II as HSP90 inhibitors |
05/27/2009 | CN101440086A Halogenated pyrrole substituted indolinones, and intermediate, preparation and use thereof |
05/27/2009 | CN101439039A Fortifier |
05/27/2009 | CN100491372C Substituted quinazoline derivatives as inhibitors of aurora kinases |
05/27/2009 | CN100491371C Heteroaryl amines as glycogen synthase kinase 3beta inhibitors (GSK3 inhibitors) |
05/27/2009 | CN100491359C 2-amino-4-bicyclyl amino-6h-1.3.5-triazines, method for the production and use thereof as herbicides and plant growth regulators |
05/27/2009 | CN100491358C Pyrimidinone compounds, compositions and methods |
05/27/2009 | CN100491355C Cyclic diamine compound having five-membered cyclic group |
05/27/2009 | CN100491353C Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor |
05/27/2009 | CN100491351C Polymeric charge transport compositions and electronic devices made with such compositions |
05/27/2009 | CN100491349C Antiviral agent |
05/27/2009 | CN100491348C Thrombosis resisting preparation |
05/26/2009 | US7538215 Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
05/26/2009 | US7538133 Benzimidazole derivatives, their production and use |
05/26/2009 | US7538121 Vanilloid receptor modulators |
05/26/2009 | CA2474373C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substituent on the methyl useful as bradykinin antagonists |
05/26/2009 | CA2463264C 3-azabicyclo (3.1.0) hexane derivatives as opioid receptor antagonists |
05/26/2009 | CA2459432C Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders |
05/26/2009 | CA2393821C Substituted imidazole neuropeptide y y5 receptor antagonists |
05/26/2009 | CA2340701C Oxindole derivatives as growth hormone releasers |
05/26/2009 | CA2254420C Substituted imidazolidine derivatives, their preparation, their use and pharmaceutical preparations comprising them |
05/26/2009 | CA2216653C 1,3-dihydro-1-(phenylalkyl)-2h-imidazol-2-one derivatives having pdeiv and cytokine activity |
05/22/2009 | WO2009064848A1 3-heterocyclic substituted indole derivatives and methods of use thereof |
05/22/2009 | WO2009064835A1 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin-2-amines as janus kinase inhibitors |
05/22/2009 | WO2009064418A1 Substituted hydroxyethyl amine compounds as beta-secretase modulators and methods of use |
05/22/2009 | WO2009063953A1 Phenylpyrazole derivatives |
05/22/2009 | WO2009063365A1 Azetidines as ep2 antagonists |
05/22/2009 | WO2009063244A1 Pyridazinone derivatives as parp inhibitors |
05/22/2009 | WO2009063061A2 Aryl- and heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
05/22/2009 | WO2009063054A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
05/22/2009 | WO2009062658A1 Methods for identification of jak kinase interacting molecules and for the purification of jak kinases |
05/22/2009 | WO2009062319A1 Indole compounds and methods for treating visceral pain |
05/22/2009 | WO2009035296A3 Organic compound, and organic photoelectric device including the same |
05/22/2009 | WO2008142576A3 1,(3,)5-substituted imidazoles, their use in the treatment of hypertension and methods for their preparation |
05/22/2009 | CA2705922A1 Novel bifunctional compounds which inhibit protein kinases and histone deacetylases |
05/22/2009 | CA2705835A1 Indole compounds and methods for treating visceral pain |
05/22/2009 | CA2705586A1 3-heterocyclic substituted indole derivatives and methods of use thereof |